NovaBridge Biosciences ADR (NBP) Implied Volatility Current

Tracking NBP implied volatility helps you identify when options premiums on NovaBridge Biosciences ADR are historically cheap or expensive, and where the best trades are hiding. NovaBridge Biosciences ADR implied volatility reflects the market's expectation of future price movement: when NBP IV rises, option premiums increase, creating opportunities for sellers, and when it drops, buyers can find cheaper contracts. Use our scanner to monitor NovaBridge Biosciences ADR's implied volatility current levels in real time and filter for high-probability trades.

Implied volatility is derived from option prices using models like Black-Scholes and represents the annualized expected move of an underlying stock. For NBP, tracking metrics like NBP IV rank helps traders understand whether current implied volatility is historically high or low. IV rank compares today's reading against the past year's range — a high rank on NBP signals rich premiums and potential mean-reversion, while a low rank may favor long options strategies.

NovaBridge Biosciences, a biotech company, focuses on the development of immuno-oncology agents for the treatment of cancer in the United States. The company is developing givastomig, a bispecific antibody, which is in Phase 1b clinical trial for the treatment of gastric cancer; uliledlimab, a CD73 neutralizing antibody; and ragistomig, a bispecific antibody, which is in phase 1 clinical trial for the treatment of solid tumors. It has a strategic licensing agreement with Ferring International Center SA to research, develop, make, have made, import, use, sell, and offer to sell FE301, an interleukin-6 inhibitor.

The company also has collaborations with Bristol Myers Squibb for the development of givastomig; ABL Bio, Inc. for the development of givastomig and ragistomig; and TJ Bio for the development of uliledlimab. The company was formerly known as I-Mab and change its name to NovaBridge Biosciences in October 2025. NovaBridge Biosciences was founded in 2014 and is headquartered in Rockville, Maryland.

Premium sellers, directional traders, and spread builders all need the same starting point: a clear read on where NBP implied volatility sits today versus where it has been. Our scanner ranks NovaBridge Biosciences ADR implied volatility against its historical range, surfaces extremes in NBP IV rank, and pairs every reading with the trades that exploit it. Stop guessing whether NovaBridge Biosciences ADR IV is rich or cheap — measure it, then act on it.